Intralesional Steroid Injection Versus Extracorporeal Shockwave Therapy in the Treatment of Plantar Fasciitis: A Comparative, Prospective, Case Series Study.

Autor:	Rai S; Orthopaedics, Military Hospital Ambala, Ambala, IND., Rajauria S; Pathology and Laboratory Medicine, Maharishi Markandeshwar Institute of Medical Sciences and Research, Ambala, IND., Khandelwal N; Pathology, Military Hospital Ambala, Ambala, IND., Reddy DC; Radiology, Military Hospital Ambala, Ambala, IND., Gupta TP; Orthopaedics, Base Hospital Delhi Cantt, Delhi, IND.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2023 Jan 10; Vol. 15 (1), pp. e33593. Date of Electronic Publication: 2023 Jan 10 (Print Publication: 2023).
DOI:	10.7759/cureus.33593
Abstrakt:	Background This study aimed to compare and evaluate the outcomes of intralesional steroid injections (ultrasound-guided) versus extracorporeal shockwave therapy in the treatment of plantar fasciitis. Methodology Between January 2021 and March 2022, 120 (84 male, 36 female) patients with a confirmed diagnosis of plantar fasciitis were identified. Subjective assessment was done using Mayo Clinical Score, and objective evaluation was done by measuring plantar fascia thickness using ultrasonography. For this study, two groups were made, wherein group A was administered a high dose of extracorporeal shockwave therapy, and group B was administered ultrasound-guided intralesional or local steroid injections. Results Plantar fascia thickness was considerably reduced after therapy in both groups; however, the difference in thickness reduction was not statistically significant between both groups. Mayo Clinic Scores showed statistically significant improvement in pain; however, the difference in pain reduction was not statistically significant between both groups. Conclusions A considerable clinical and radiological improvement was noted in both groups; however, we did not record statistically significant and superior results in either group. Intralesional steroid injections provided faster clinical improvement and better patient compliance. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Rai et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu